Perrigo Company plc Property, Plant and Equipment, Additions
Perrigo Company plc (PRGO) reported Property, Plant and Equipment, Additions of $94.30 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes
us-gaap:PropertyPlantAndEquipmentAdditions · last filed 2023-02-28
- Perrigo Company plc property, plant and equipment, additions for fiscal 2022 was $94.30M, a 30.66% decline from fiscal 2021.
- Perrigo Company plc property, plant and equipment, additions for fiscal 2021 was $136.00M, a 15.11% decline from fiscal 2020.
- Perrigo Company plc property, plant and equipment, additions for fiscal 2020 was $160.20M, a 31.96% increase from fiscal 2019.
- Perrigo Company plc property, plant and equipment, additions for fiscal 2019 was $121.40M, a 18.21% increase from fiscal 2018.
| Period end | Property, Plant and Equipment, Additions 6 month | Property, Plant and Equipment, Additions 12 month | Property, Plant and Equipment, Additions 12 month as first filed |
|---|---|---|---|
| 2022-12-31 | $94.30M 10-K · filed 2023-02-28 | ||
| 2021-12-31 | $136.00M 10-K · filed 2023-02-28 | ||
| 2020-12-31 | $160.20M 10-K · filed 2023-02-28 | $170.40M 10-K · filed 2021-03-01 | |
| 2019-12-31 | $121.40M 10-K · filed 2022-03-01 | $137.70M 10-K · filed 2020-02-27 | |
| 2018-12-31 | $102.70M 10-K · filed 2021-03-01 | $102.60M 10-K · filed 2019-02-27 | |
| 2017-12-31 | $88.60M 10-K · filed 2020-02-27 | ||
| 2016-12-31 | $106.20M 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $77.80M 10-K · filed 2018-03-01 | ||
| 2015-06-27 | $137.00M 10-K · filed 2018-03-01 | ||
| 2014-06-28 | $171.60M 10-K · filed 2017-05-22 | ||
| 2013-12-28 | $171.60M 10-KT · filed 2016-02-25 | ||
| 2013-06-29 | $132.20M 10-KT · filed 2016-02-25 | ||
| 2012-06-30 | $120.20M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |